Causaly is hosting a second session of its Clinical Development series on September 9, 2026, where the Science Team will demonstrate evidence work behind an active trial.
Published
Signal category
Presence & Recognition
Quote
“Join us tomorrow, September 9, as we take these questions into the second session of our Clinical Development series.”
— Causaly team
Company
Causaly
Unlock R&D productivity with the most complete AI platform for life sciences.
- Industry
- Software Development
- Location
- London, GB
- Company size
- 120 employees
Our mission at Causaly is to redefine the boundaries of human discovery by harnessing transformative AI technologies. Founded in 2018, Causaly’s unique AI platform is a powerful catalyst for the modern Life Science research organization, reshaping how data is found, analyzed and applied in critical decision-making processes in drug discovery and development. Supporting a broad range of complex knowledge workflows, our platform accelerates the journey from bench research and laboratory insights to the launch of life-changing therapies.
Founded 2018